Olmesartan-associated Enteropathy with Acute Kidney Injury / 대한소화기학회지
The Korean Journal of Gastroenterology
; : 130-134, 2022.
Article
em En
| WPRIM
| ID: wpr-926974
Biblioteca responsável:
WPRO
ABSTRACT
Olmesartan, a recently introduced angiotensin II receptor blocker for hypertension, has been reported to cause drug-induced small bowel enteropathy. The diagnosis of olmesartan-associated enteropathy (OAE) needs clinical suspicion and the exclusion of coeliac disease, as it mimics coeliac sprue. Once diagnosed, it can be completely cured with the discontinuation of olmesartan. However, due to the extremely low incidence of OAE in Korea, clinical suspicion and diagnosis may be a challenge. The authors report the first case of OAE presenting with chronic diarrhea and acute kidney injury in Korea.
Texto completo:
1
Índice:
WPRIM
Idioma:
En
Revista:
The Korean Journal of Gastroenterology
Ano de publicação:
2022
Tipo de documento:
Article